Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Haemonetics (HAE) Inventory Average (2016 - 2025)

Historic Inventory Average for Haemonetics (HAE) over the last 16 years, with Q4 2025 value amounting to $328.7 million.

  • Haemonetics' Inventory Average rose 8481.35% to $328.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $328.7 million, marking a year-over-year increase of 8481.35%. This contributed to the annual value of $341.2 million for FY2025, which is 1834.3% up from last year.
  • Haemonetics' Inventory Average amounted to $328.7 million in Q4 2025, which was up 8481.35% from $348.4 million recorded in Q3 2025.
  • In the past 5 years, Haemonetics' Inventory Average registered a high of $377.9 million during Q3 2024, and its lowest value of $169.4 million during Q1 2025.
  • Its 5-year average for Inventory Average is $295.8 million, with a median of $305.0 million in 2022.
  • Data for Haemonetics' Inventory Average shows a peak YoY increase of 8481.35% (in 2025) and a maximum YoY decrease of 4547.22% (in 2025) over the last 5 years.
  • Quarter analysis of 5 years shows Haemonetics' Inventory Average stood at $324.6 million in 2021, then dropped by 21.37% to $255.2 million in 2022, then grew by 15.56% to $294.9 million in 2023, then crashed by 39.7% to $177.9 million in 2024, then skyrocketed by 84.81% to $328.7 million in 2025.
  • Its Inventory Average was $328.7 million in Q4 2025, compared to $348.4 million in Q3 2025 and $362.8 million in Q2 2025.